Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis

• Hoofdauteurs: Kate T Simms, DrPhD (Auteur), Jean-François Laprise, PhD (Auteur), Megan A Smith, MPH (Auteur), Jie-Bin Lew, MPH (Auteur), Michael Caruana, DPhil (Auteur), Marc Brisson, ProfPhD (Auteur), Karen Canfell, ProfDPhil (Auteur)
• Formaat: Boek
• Gepubliceerd in: Elsevier, 2016-12-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Summary: Background: First generation bivalent and quadrivalent human papillomavirus (HPV) vaccines have been introduced in most developed countries. A next generation nonavalent vaccine (HPV9) has become available, just as many countries are considering transitioning from cytology-based to HPV-base...